The stock of Indoco Remedies will remain in focus on the bourses, as the company informed the exchanges, after market hours, about receiving the US Food & Drugs Administration’s approval for its facility in Goa.
Based on the inspection carried out by the USFDA in August 2013, Indoco Remedies has received Establishment Inspection Report approving the company’s sterile plant and solid dosage facility in Goa. Analysts will be watching the developments.